Atrium Health

Charlotte, North Carolina 28211

29 studies enrolling now · 101 studies all time

What they study most

Acute Cerebrovascular Disease, Acute Coronary Syndrome, Acute Respiratory Distress Syndrome, Acute; Myocardial Infarction, Complications, Alcoholic Hepatitis, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Aorta; Lesion, Aortic Aneurysm, Aortic Aneurysm, Thoracic, Aortic Dissection, Aortoiliac Occlusive Disease

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Recruiting now
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study — Recruiting now
• GORE® ENFORM Biomaterial Product Study — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer — Recruiting now
• Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) — Recruiting now
• Prophylactic Reinforcement of Ventral Abdominal Incisions Trial — Recruiting now
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) — Recruiting now
• Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults — Recruiting now
• The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease — Recruiting now
• DISCOVERY of Risk Factors for Type 2 Diabetes in Youth — Recruiting now
• CIED Infection Quality Initiative Demonstration Project — Recruiting now
• Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy — Recruiting now
• COMPARE - Pediatric Inflammatory Bowel Disease (PIBD) — Recruiting now
• PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia — Recruiting now
• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) — Recruiting now
• US National OCS Heart Perfusion (OHP) Registry — Recruiting now
• Individualizing Treatment for Asthma in Primary Care (Full Study) — Recruiting now
• NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness — Recruiting now
• Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
• A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age — Starting soon
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• Primary Care Implementation and Evaluation of Coach McLungs — Running, not enrolling
• A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia — Running, not enrolling
• Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia — Running, not enrolling
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) — Running, not enrolling
• TRIAD Appendicitis Decision-making Surveys — Completed
• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
• Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) — Running, not enrolling
• Evaluation of the GORE® Ascending Stent Graft — Enrolling by invitation
• INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery — Starting soon
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Venclose digiRF System Post Market Study — Running, not enrolling
• Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs — Completed
• Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence — Running, not enrolling
• GATT-Patch Versus TachoSil in Liver Surgery — Completed
• Molecular Assessment and Profiling of Liver Transplant Recipients — Running, not enrolling
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery — Completed
• Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis — Withdrawn before enrolling
• Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up — Completed
• A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy — Running, not enrolling